Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs121918474
rs121918474
0.010 GeneticVariation BEFREE The possibility of PS K196E mutation should be considered if other causes of CVT are ruled out and if protein S activity is decreased. 30352753

2019

dbSNP: rs2146881
rs2146881
0.010 GeneticVariation BEFREE We analyzed the association between CVT and TAFI single-nucleotide polymorphisms (rs3742264, rs2146881, and rs1926447) compared to healthy controls. 29629564

2018

dbSNP: rs8176719
rs8176719
ABO
0.010 GeneticVariation BEFREE Single variant association testing using logistic regression analysis identified rs8176719 insertion/deletion (indel) variant in the ABO gene associated with CVT (age and sex adjusted OR 2.03; 95% CI 1.52-2.73; P = 2.07 × 10<sup>-6</sup>; Bonferroni P = 0.008). 30029070

2018

dbSNP: rs189468720
rs189468720
0.010 GeneticVariation BEFREE SNP analysis revealed HOXC11 p.Ser191Phe segregating with clubfoot in a small family and enrichment of HOXC12 p.Asn176Lys in patients with clubfoot or vertical talus (rs189468720, p=0.0057, OR=3.8). 26729820

2016

dbSNP: rs397507444
rs397507444
0.010 GeneticVariation BEFREE To our knowledge, there are no previous reports assessing the correlation between the MTHFR A1298C variant and CVT. 23314385

2013

dbSNP: rs1188383936
rs1188383936
F2
0.010 GeneticVariation BEFREE However, neither the FII-G20210 (p=0.536) nor the homozygous MTHFR-C677T genotype (p=0.325) variant contributed to the risk of CVT in these Tunisian patients. 22721898

2012

dbSNP: rs201058276
rs201058276
F7
0.010 GeneticVariation BEFREE Our findings suggest that the FVII R353Q polymorphism is not associated with increased risk for CVT occurring during the puerperal period in Indian women. 22136731

2012

dbSNP: rs368927897
rs368927897
0.010 GeneticVariation BEFREE Statistically significant associations with CVT were found for factor V Leiden/G1691A (OR=2.40; 95% CI, 1.75 to 3.30; P<0.00001) and prothrombin/G20210A (OR=5.48; 95% CI, 3.88 to 7.74; P<0.00001). 21350198

2011

dbSNP: rs3742264
rs3742264
0.020 GeneticVariation BEFREE We analyzed the association between CVT and TAFI single-nucleotide polymorphisms (rs3742264, rs2146881, and rs1926447) compared to healthy controls. 29629564

2018

dbSNP: rs3742264
rs3742264
0.020 GeneticVariation BEFREE Our data indicate that the GTC haplotype for TAFI 505G>A/1040C>T/+1542C>G SNPs increased the risk of CVT in comparison to controls and VTE cases. 24252537

2014

dbSNP: rs751377893
rs751377893
F5
0.020 GeneticVariation BEFREE We performed a study to evaluate the role of three single nucleotide polymorphisms (SNP), factor V Leiden G1691A (FVL), prothrombin gene mutation G20210A (FII-G20210A) and methylenotetrahydrofolate reductase variant C677T (MTHFR-C677T), as risk factors for CVT in Tunisian patients. 22721898

2012

dbSNP: rs899127658
rs899127658
F2
0.020 GeneticVariation BEFREE We performed a study to evaluate the role of three single nucleotide polymorphisms (SNP), factor V Leiden G1691A (FVL), prothrombin gene mutation G20210A (FII-G20210A) and methylenotetrahydrofolate reductase variant C677T (MTHFR-C677T), as risk factors for CVT in Tunisian patients. 22721898

2012

dbSNP: rs751377893
rs751377893
F5
0.020 GeneticVariation BEFREE Statistically significant associations with CVT were found for factor V Leiden/G1691A (OR=2.40; 95% CI, 1.75 to 3.30; P<0.00001) and prothrombin/G20210A (OR=5.48; 95% CI, 3.88 to 7.74; P<0.00001). 21350198

2011

dbSNP: rs899127658
rs899127658
F2
0.020 GeneticVariation BEFREE Statistically significant associations with CVT were found for factor V Leiden/G1691A (OR=2.40; 95% CI, 1.75 to 3.30; P<0.00001) and prothrombin/G20210A (OR=5.48; 95% CI, 3.88 to 7.74; P<0.00001). 21350198

2011

dbSNP: rs1926447
rs1926447
0.030 GeneticVariation BEFREE In conclusion, TAFI rs3742264, rs2146881, and rs1926447 polymorphisms do not increase the risk of CVT in comparison to healthy controls. 29629564

2018

dbSNP: rs1926447
rs1926447
0.030 GeneticVariation BEFREE For genetic factors, CVT risk increased in the presence of factor V Leiden (G1691A) by 2.5-fold (1.9-3.3), protein C deficiency 10.7-fold (3.1-37.7), protein S deficiency 5.7-fold (1.4-22.4), antithrombin deficiency 3.8-fold (1.0-13.8), prothrombin (G20210A) 5.5-fold (4.0-7.27) and TAFI gene variant (C1040T) 1.6-fold (1.0-2.4). 30005273

2018

dbSNP: rs77375493
rs77375493
0.030 GeneticVariation BEFREE Screening for the JAK2 V617F mutation in CVT patients seems to be useful even in the absence of overt MPN and/or in the presence of other risk factors for CVT because of its relatively high prevalence and the risk of thrombosis recurrence. 28609766

2017

dbSNP: rs1926447
rs1926447
0.030 GeneticVariation BEFREE Our data indicate that the GTC haplotype for TAFI 505G>A/1040C>T/+1542C>G SNPs increased the risk of CVT in comparison to controls and VTE cases. 24252537

2014

dbSNP: rs77375493
rs77375493
0.030 GeneticVariation BEFREE Thrombophilia abnormalities were significantly more prevalent in the MPN-CVT and MPN-VT than in MPN-NoT group (P = 0.015), as well as the JAK2 V617F mutation in patients with essential thrombocythemia (P = 0.059). 25042466

2014

dbSNP: rs1217691063
rs1217691063
0.030 GeneticVariation BEFREE However, neither the FII-G20210 (p=0.536) nor the homozygous MTHFR-C677T genotype (p=0.325) variant contributed to the risk of CVT in these Tunisian patients. 22721898

2012

dbSNP: rs77375493
rs77375493
0.030 GeneticVariation BEFREE JAK2 V617F was positive in four out of seven patients with PVT and in one CVT patient. 21893442

2011

dbSNP: rs1217691063
rs1217691063
0.030 GeneticVariation BEFREE We report a case of cerebral venous thrombosis (CVT) due to tyrotoxicosis in a patient with methylenetetrahydro-folate-reductase (MTHFR) gene polymorphism C677T, (genotype 677TT), in which discontinuation of intravenous heparin was followed by clinical and radiological worsening despite warfarin treatment. 18941937

2008

dbSNP: rs1217691063
rs1217691063
0.030 GeneticVariation BEFREE We report three patients with cerebral vein thrombosis (CVT) in which the only risk factor we were able to identify was increased blood homocysteine levels and the C677T polymorphism in both alleles of the methylene tetrahydrofolate reductase MTHFR gene. 12522678

2002

dbSNP: rs1207534366
rs1207534366
G 0.700 CausalMutation CLINVAR

dbSNP: rs121908425
rs121908425
T 0.700 CausalMutation CLINVAR